Solstice Advanced Materials Announces Expansion of Uranium Conversion Production to Support Strong Nuclear Industry Customer Demand

Rhea-AI Summary

Solstice Advanced Materials (NASDAQ: SOLS) projects Metropolis Works to produce over 10 kilotonnes (10 kt) of UF6 in 2026, about a 20% increase from planned 2024 capacity. The expansion follows debottlenecking since the 2023 restart and is supported by a backlog of over $2 billion.

Solstice is exploring further debottlenecking and new capacity investments, has retained an EPC firm for initial engineering analysis, and is engaging in long-term supply discussions with customers. Metropolis Works is the only UF6 conversion facility in the U.S. and holds an NRC license valid through 2060.

Positive

• Production projected >10 kt UF6 in 2026 (~20% increase vs 2024)
• Backlog of over $2 billion driven by long-term customers
• Only UF6 conversion facility in the United States (Metropolis Works)
• NRC operating license at Metropolis Works valid through 2060

Negative

• Operational concentration: single U.S. UF6 conversion facility creates a single-point operational risk
• Planned capacity increases require further capital and engineering work, implying potential execution or funding risk

Key Figures

UF6 production 2026: over 10 kilotonnes (10 kt) Capacity expansion: about 20% Order backlog: over $2 billion +5 more

8 metrics

UF6 production 2026 over 10 kilotonnes (10 kt) Projected Metropolis Works uranium hexafluoride output in 2026

Capacity expansion about 20% Increase vs planned 2024 UF6 output at Metropolis Works

Order backlog over $2 billion Backlog supporting UF6 conversion expansion

Operational track record 60-plus years Operational excellence and industry leadership cited by management

US nuclear goal quadrupling by 2050 U.S. policy goal for American nuclear energy capacity

US electricity share nearly 20% Portion of U.S. electricity generated by nuclear reactors

Facility license term valid until 2060 NRC license for Metropolis Works UF6 conversion facility

Vanguard ownership 11.58% Schedule 13G/A beneficial ownership of Solstice common stock

Market Reality Check

Price: $63.80 Vol: Volume 2,555,894 is rough...

normal vol

$63.80 Last Close

Volume Volume 2,555,894 is roughly in line with the 20-day average of 2,673,297 (relative volume 0.96). normal

Technical Shares at $63.80 are trading above the 200-day MA of $17.83 and about 5.82% below the 52-week high of $67.74.

Historical Context

5 past events · Latest: Feb 06 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 06	Conference participation	Neutral	+2.2%	CEO scheduled for fireside chat at Barclays Industrial Select Conference.
Jan 13	Capacity expansion	Positive	+5.8%	Plans >$220M ballistic fiber expansion and 100 high-tech jobs in Virginia.
Jan 07	Earnings timing	Neutral	+4.5%	Announcement of Q4 2025 results release date and conference call details.
Dec 22	Spin-related update	Negative	-0.4%	Honeywell adjusts guidance and treats Advanced Materials as discontinued ops post spin.
Dec 02	Semicon expansion	Positive	-2.2%	Announces $200M Spokane expansion to double sputtering-target capacity by 2029.

Pattern Detected

Recent company-specific news has often seen positive or modestly positive price reactions, with one notable divergence on a large capex expansion.

Recent Company History

Over the last several months, Solstice has highlighted multiple growth and portfolio transitions. It broke ground on a $200 million Spokane expansion to double sputtering-target capacity by 2029, and later announced a >$220 million ballistic fiber expansion in Virginia with new high-tech jobs through 2030. The Honeywell spin-related update framed Solstice’s business as discontinued operations at the parent. More recently, Solstice set a date for its Q4 2025 earnings release and disclosed upcoming conference participation. Today’s UF6 capacity expansion fits this pattern of sizable, long-dated growth investments.

Market Pulse Summary

This announcement underscores Solstice’s role in the nuclear fuel supply chain, with projected UF6 o...

Analysis

This announcement underscores Solstice’s role in the nuclear fuel supply chain, with projected UF6 output of over 10 kt in 2026 and a backlog above $2 billion. It extends a recent pattern of large, multi-year capacity investments across end markets. Investors may focus on utilization of the Metropolis Works facility, long-term contract quality, and progress updates on engineering studies for additional capacity as key markers of how effectively this expansion translates into sustained financial performance.

Key Terms

u.s. nuclear regulatory commission

1 terms

u.s. nuclear regulatory commission regulatory

"facility, which holds a license from the U.S. Nuclear Regulatory Commission that is valid until 2060."

A federal agency that licenses, inspects and enforces safety rules for civilian nuclear power plants and other uses of radioactive materials in the United States. Think of it as the official safety inspector and rulemaker for the nuclear industry—its approvals, inspections, fines and rule changes can speed up or delay projects, change operating costs, and alter legal and financial risk, so its actions directly affect companies’ prospects and investor value.

AI-generated analysis. Not financial advice.

Driven by rising demand, expected 2026 production of over 10 kilotonnes of uranium hexafluoride (UF₆) in 2026 would represent an approximate 20% expansion from planned 2024 capacity

Company to explore further debottlenecking at its facility and new capacity investments; current backlog is over $2 billion

MORRIS PLAINS, N.J., Feb. 10, 2026 /PRNewswire/ -- Solstice Advanced Materials, (NASDAQ: SOLS), a global leader in high-performance specialty materials, today announced that its Metropolis Works, Ill., facility is projected to produce over 10 kilotonnes (10 kt) of uranium hexafluoride (UF₆) in 2026, which represents about a 20% increase from its planned output in 2024.

The company has invested in debottlenecking projects at Metropolis Works following its 2023 restart in response to strong customer demand for UF₆, a critical component in the nuclear fuel supply chain. Metropolis Works is the only UF₆ conversion facility in the United States. The company's expansion efforts are underpinned by its backlog of over $2 billion driven by orders from long-term customers, many of which are domestic utility companies, as well as the United States' policy goal of quadrupling American nuclear energy capacity by 2050.

Backed in part by the U.S. Department of Energy (DOE), Solstice is actively exploring additional projects to increase production at its Metropolis Works facility. Solstice has also retained a leading engineering, procurement and construction firm to conduct an initial engineering analysis for new capacity expansion investments and, at the same time, has initiated long-term supply discussions with customers.

"Solstice has stepped up production of UF₆, a critical component in the nuclear fuel supply chain, with the support of disciplined capital investments and improved operational excellence at our Metropolis Works facility," said David Sewell, Solstice President and CEO. "Leveraging our 60-plus years of operational excellence, industry leadership and proprietary expertise, we are exceedingly well-positioned to ensure our capacity to produce converted uranium is aligned with the industry and its rapid expansion."

Solstice's Metropolis Works facility converts uranium ore concentrate from global mines into UF₆ using Solstice's proprietary process, which is recognized for its efficiency and reliability. After Solstice's conversion process, UF₆ is enriched and fabricated by other service providers into nuclear fuel that powers reactors generating nearly 20% of U.S. electricity and representing the largest single source of carbon-free energy in the country, according to the World Nuclear Association.

ConverDyn, a partnership between Solstice and General Atomics, serves as the exclusive marketing agent for all UF₆ produced at the Metropolis Works facility, which holds a license from the U.S. Nuclear Regulatory Commission that is valid until 2060.

About Solstice Advanced Materials
Solstice Advanced Materials is a leading global specialty materials company that advances science for smarter outcomes. Solstice offers high-performance solutions that enable critical industries and applications, including refrigerants, semiconductor manufacturing, data center cooling, nuclear power, protective fibers, healthcare packaging and more. Solstice is recognized for developing next-generation materials through some of the industry's most renowned brands such as Solstice^®, Genetron^®, Aclar^®, Spectra^®, Fluka™ and Hydranal™. Partnering with over 3,000 customers across more than 120 countries and territories and supported by a robust portfolio of over 5,700 patents and pending applications, Solstice's approximately 4,000 employees worldwide drive innovation in materials science.

For more information, visit www.solstice.com.

Forward-Looking Statements
This news release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the fact that they do not relate strictly to historical or current facts, but rather are based on current expectations, estimates, assumptions and projections. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include, without limitation, ongoing macroeconomic and geopolitical risks, such as changes in or application of trade and tax laws and policies, including the impacts of tariffs and other trade barriers and restrictions, lower GDP growth or recession in the U.S. or globally, supply chain disruptions, capital markets volatility, and inflation, that can affect Solstice's performance in both the near- and long-term. In addition, no assurance can be given that any plan, initiative, projection, goal, commitment, expectation, or prospect set forth in this release can or will be achieved. These forward-looking statements should be considered in light of the information included in this release, Solstice's final information statement, dated October 17, 2025, and other filings with the Securities and Exchange Commission. Any forward-looking plans described herein are not final and may be modified or abandoned at any time. Solstice does not undertake to update or revise any of its forward-looking statements, which speak only as of the date they are made.

Contacts:

Media	Investor Relations
Amy Schneiderman	Mike Leithead
(201) 218-2302	(973) 370-8188
Amy.Schneiderman@teneo.com	Michael.Leithead@solstice.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/solstice-advanced-materials-announces-expansion-of-uranium-conversion-production-to-support-strong-nuclear-industry-customer-demand-302684108.html

SOURCE Solstice Advanced Materials US, Inc.

FAQ

How much UF6 production is Solstice (SOLS) projecting for 2026?

Solstice projects Metropolis Works will produce over 10 kilotonnes (10 kt) of UF6 in 2026. According to the company, this represents about a 20% increase from planned 2024 capacity after debottlenecking investments and the 2023 restart.

What backlog does Solstice (SOLS) report and what does it mean for revenue visibility?

Solstice reports a backlog of over $2 billion, indicating strong contracted demand. According to the company, the backlog is driven by long-term customers, many domestic utilities, supporting near-term revenue visibility for UF6 sales.

Is Metropolis Works the only UF6 conversion facility in the United States for SOLS?

Yes. Metropolis Works is described as the only UF6 conversion facility in the United States. According to the company, that status concentrates domestic conversion capacity at its site and underpins its strategic role in the U.S. nuclear fuel supply chain.

Does Solstice (SOLS) have regulatory clearance to operate Metropolis Works long-term?

Metropolis Works holds an NRC license that is valid until 2060. According to the company, this long-term license supports ongoing UF6 production and commercial planning through mid-century under current regulatory authorization.

What does Solstice’s 2026 production expansion mean for SOLS shareholders?

The production increase signals potential revenue growth from higher UF6 output and backlog conversion. According to the company, expansion efforts and customer contracts may support future cash flows but require capital and execution to realize shareholder value.